MARKET

AXGN

AXGN

Axogen Inc
NASDAQ
35.30
+0.29
+0.83%
After Hours: 35.30 0 0.00% 17:09 02/20 EST
OPEN
35.18
PREV CLOSE
35.01
HIGH
35.80
LOW
34.55
VOLUME
563.59K
TURNOVER
--
52 WEEK HIGH
36.00
52 WEEK LOW
9.22
MARKET CAP
1.77B
P/E (TTM)
-726.3374
1D
5D
1M
3M
1Y
5Y
1D
First Eagle Small Cap Opportunity Fund Q4 2025 Portfolio Review
Seeking Alpha · 2d ago
Beyond The Numbers: 6 Analysts Discuss Axogen Stock
Benzinga · 3d ago
This Tempus AI Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga · 3d ago
Axogen Price Target Announced at $40.00/Share by Wells Fargo
Dow Jones · 3d ago
Wells Fargo Initiates Coverage On Axogen with Overweight Rating, Announces Price Target of $40
Benzinga · 3d ago
AXOGEN, INC. <AXGN.O>: WELLS FARGO INITIATES COVERAGE WITH OVERWEIGHT RATING AND TARGET PRICE $40
Reuters · 3d ago
AxoGen initiated with an Overweight at Wells Fargo
TipRanks · 3d ago
U.S. RESEARCH ROUNDUP-EBay, Huntsman, Palo Alto
Reuters · 3d ago
More
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

Webull offers AxoGen Inc stock information, including NASDAQ: AXGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AXGN stock methods without spending real money on the virtual paper trading platform.